TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial - The Lancet Oncology
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination - ScienceDirect
Studies evaluating TAS-102 and ctDNA are highlighted in ASCO GI 2021 - Onco Americas
HEALTHCARE PROFESSIONALS
Result of the PII trial of TAS-102 in third/fourth line colorectal... | Download Scientific Diagram
Trifluridine/tipiracil hydrochloride mixture (TAS-102) | Nucleoside Antitumour Agent | MedChemExpress
Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS‐ 102) | Semantic Scholar
Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer | Anticancer Research
TAS-102 (trifluridine/tipiracil)…ยาสูตรผสมสำหรับรักษาโรคมะเร็งลำไส้ใหญ่และไส้ตรง
Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer | Anticancer Research
Chemorefractory Metastatic Colorectal Cancer: TAS ppt download
JCM | Free Full-Text | Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
File:TAS-102 - Fluridine and Tipiracil Mechanism of Action (2).svg - Wikimedia Commons
File:TAS-102 - Fluridine and Tipiracil Mechanism of Action.png - Wikipedia
TAS-102, a novel antitumor agent: A review of the mechanism of action - ScienceDirect
TAS-102 – Absource Diagnostics
Comparison of the mechanisms of action of TAS-102 and 5-FU. 5-FU... | Download Scientific Diagram
Gastric Cancer Foundation lonsurf Archives | Gastric Cancer Foundation
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer? - The Lancet Oncology
Department of Clinical Oncology
Mechanism of action of TAS-102. | Download Scientific Diagram
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer - ScienceDirect
TAS-102 in mCRC - Slideset Download - Clin Onc June 2016 | CCO
